1. Home
  2. NWSA vs MDGL Comparison

NWSA vs MDGL Comparison

Compare NWSA & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo News Corporation

NWSA

News Corporation

HOLD

Current Price

$26.03

Market Cap

14.6B

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$526.36

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWSA
MDGL
Founded
2012
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.6B
12.0B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
NWSA
MDGL
Price
$26.03
$526.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
12
Target Price
$37.94
$674.45
AVG Volume (30 Days)
4.6M
352.5K
Earning Date
05-07-2026
04-28-2026
Dividend Yield
0.78%
N/A
EPS Growth
N/A
41.32
EPS
N/A
N/A
Revenue
N/A
$180,133,000.00
Revenue This Year
$6.06
$58.39
Revenue Next Year
$3.25
$48.55
P/E Ratio
$11.53
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.20
$265.00
52 Week High
$31.61
$615.00

Technical Indicators

Market Signals
Indicator
NWSA
MDGL
Relative Strength Index (RSI) 68.80 61.75
Support Level $25.80 $503.93
Resistance Level $27.04 $610.00
Average True Range (ATR) 0.53 19.22
MACD 0.15 -0.29
Stochastic Oscillator 90.19 56.33

Price Performance

Historical Comparison
NWSA
MDGL

About NWSA News Corporation

News Corporation is a diversified media conglomerate with large presence in the US, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. Its 61%-owned REA Group is the dominant property listings platform in Australia. In addition, it owns Harper Collins, one of the largest book publishers in the world, and has a sizable US digital property advertising business, Move. The 65% interest in Foxtel, the Australian pay-TV and streaming provider, was sold in April 2025. The sale to global sports streaming platform, DAZN, was struck at more than 7 times Foxtel's EBITDA.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: